European Journal of Neurology

Article	Citations
	144
Clinical and Genetic Reassessment in Patients With Clinically Diagnosed Hereditary Polyneuropathy	97
Concerns Regarding “Small Fiber Morphology and Function in Inclusion Body Myositis—A Multimodal Assessment Including Confocal Corneal Microscopy”	95
	95
Issue Information	89
Structural correlations between brain magnetic resonance image‐derived phenotypes and retinal neuroanatomy	88
Central nervous system crystal‐storing histiocytosis: A case report and literature review	81
ePoster	76
Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis	73
Lessons from the past to understand the future	71
CCR5‐Δ32polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients	71
Clusters of Comorbidities in Multiple Sclerosis and Their Influence on Healthcare Resource Usage	68
Out‐of‐hospital versus in‐hospital status epilepticus: The role of etiology and comorbidities	63
Neuropathy in GAA‐FGF14 Late‐Onset Cerebellar Ataxia (SCA27B): Prevalence and Characteristics	57
COQ2 and SNCA polymorphisms interact with environmental factors to modulate the risk of multiple system atrophy and subtype disposition	54
Ischaemic cerebral small vessel disease caused by adenosine deaminase 2 deficiency syndrome	53
The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective	53
Hearing impairment and development of parkinsonism and possible rapid eye movement sleep behaviour disorder: A CLSA prospective population‐based study	51
Basal ganglia ischaemic infarction after thrombectomy: cognitive impairment at acute stage	50
Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis	49
Cost‐effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health‐related quality of life	49
Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease	48
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study	47
Neurovascular Involvement in Fibromuscular Dysplasia: A Clue for Reappraisal of Old Classifications	46
Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case report	45

Prioritization process for European Academy of Neurology clinical practice guidelines	44
Comparative features and outcomes of major neurological complications of COVID‐19	44
The effect of influenza vaccination on the rate of dementia amongst older adults	43
Advancements in targeted therapies for generalized acetylcholine receptor antibody positive myasthenia gravis: Beginnings of a paradigm shift	43
Electroencephalography functional connectivity—A biomarker for painful polyneuropathy	43
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment	43
Diagnostic accuracy of nerve excitability and compound muscle action potential scan derived biomarkers in amyotrophic lateral sclerosis	42
Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study	42
Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients	41
Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study	41
Switching from ligand to receptor anti‐calcitonin gene‐related peptide (CGRP) antibodies or vice versa in non‐responders: A controlled cohort study	40
The microbiome–gut–brain axis in epilepsy: pharmacotherapeutic target from bench evidence for potential bedside applications	40
Response to erenumab assessed by Headache Impact Test‐6 is modulated by genetic factors and arterial hypertension: An explorative cohort study	40
Risk factors, neuroimaging correlates and prognosis of the motoric cognitive risk syndrome: A population‐based comparison with mild cognitive impairment	40
Markers of Giant Cell Arteritis in Patients Presenting With Ischemic Stroke: A Scoping Review	40
Mindfulness or meditation therapy for Parkinson's disease: A systematic review and meta‐analysis of randomized controlled trials	38
A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis	38
Correlation between patient‐reported manual ability and three objective measures of upper limb function in people with multiple sclerosis	38
Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms	38
Issue Information	37
Issue Information	37
A clinical concern: Neisseria meningitidis as a reemerging pathogen with increased antimicrobial resistance	36
Nonamyloidogenic TTR gene variants c.76G>A and c.337‐18G>C are not associated with idiopathic small‐fiber neuropathy	36
SARS‐CoV‐2 cannot unmask Parkinson's disease if there was none before infection	36
	36
Peripheral neuropathy in ataxia‐telangiectasia: Newly characterized, has potential as a biomarker	35
Ipsilateral hand impairment predicts long‐term outcome in patients with subacute stroke	35
Corrigendum to “Tremor After Solid Organ Transplantation: Results From the TransplantLines Biobank and Cohort Study”	34
Nerve Conduction Study and the Prognosis of Amyotrophic Lateral Sclerosis: Exploration of Additional Neuroelectrophysiological Parameters	34
Macroglossia: A potentially severe complication of late‐onset Pompe disease	34
Diverging medical and legal perceptions of the need for legal guardianship in people with dementia: A qualitative study	34
Treatment reduces the incidence of newly appearing multiple sclerosis lesions evolving into chronic active, slowly expanding lesions: A retrospective analysis	33
Neurology Undergraduate Medical Education: A Scoping Review	33
Hereditary Transthyretin Amyloidosis in Israel: Genetic Landscape and Clinical Characteristics	33
Issue Information	33
Causes of hospitalization and mortality in persons with epilepsy: The EpiLink Bologna cohort, Italy	32
Exploring the role of attention towards balance in chronic dizziness: Development of the Balance Vigilance Questionnaire	32
Can Non‐Thymomatous Late‐Onset Myasthenia Gravis Benefit From Thymectomy? A Systematic Review and Meta‐Analysis	32
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome	32
Epilepsy professionals' views on sudden unexpected death in epilepsy counselling: A tale of two countries	31
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease	31
Letter to the Editor: “Headache After Sealing of Cerebrospinal Fluid Leaks in Patients With Spontaneous Intracranial Hypotension”	31
Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real‐world data study	31
IgG4‐Related Disease Associated With Myotonic Dystrophy Type 2	30
First‐line steroid treatment for spontaneous intracranial hypotension	30
Alterations of Fat and Ketone Body Metabolism in ALS and SMA—A Prospective Observational Study	30
Focused Workshops	30
Dynamic Bayesian networks for stratification of disease progression in amyotrophic lateral sclerosis	30
Intraepineurial Fat Fraction: A Novel MR Neurography‐Based Biomarker in Transthyretin Amyloidosis Polyneuropathy	29
‘Positive’ inter‐ictal clinical signs of functional neurological disorders are found in patients with functional dissociative seizures	29

Lower initial red blood cell count in cerebrospinal fluid predicts good functional outcome in patients with spontaneous subarachnoid haemorrhage	29
The characteristics of intracranial plaques of unilateral, anterior circulation embolic stroke of undetermined source: An analysis of different subtypes based on high‐resolution imaging	28
Contractile properties and magnetic resonance imaging‐assessed fat replacement of muscles in myotonia congenita	28
Myoclonus in patients with COVID‐19: Findings of autoantibodies against brain structures in cerebrospinal fluid	28
Hyponatremia is associated with unfavorable outcomes after reperfusion treatment in acute ischemic stroke	28
Oral Presentations	28
Type 2 diabetes mellitus duration and subsequent risk of Alzheimer disease	27
Renal Cell Carcinoma With Unknown Primary in the Femur: The Loch Ness Monster?	27
High‐resolution magnetic resonance imaging of acute intracranial artery thrombus	27
Apolipoprotein E polymorphism ε4‐stratified longitudinal association between daytime naps, sleep apnea and mild cognitive impairment: A prospective cohort study	27
Prevalence and Spectrum of Neuropathies in a Cohort of 585 Patients With Immunoglobulin A Monoclonal Gammopathy	27
Issue Information	27
Association of symptomatic atherosclerotic carotid arteries with plaque areas showing low densities on computed tomographic angiography	26
Risk of Parkinson disease in stroke patients: A nationwide cohort study in South Korea	26
Abnormal Sleep in Chronic Inflammatory Demyelinating Polyneuropathy	26
Trajectories of physical activity after ischaemic stroke: Exploring prediction of change	26
Arterial Stiffness, Central Blood Pressure, and the Risk of Incident Stroke in Hypertensive Adults	26
Etiologic distribution of isolated abducens nerve palsy: Analysis of 807 patients and literature review	26
A Transfer Strategy Utilizing a Helicopter and a Ground Ambulance Together Does Not Prolong Door‐In‐Door‐Out Times in Thrombectomy Patients: A Retrospective Analysis	26
Hyperreflective retinal foci are associated with retinal degeneration after optic neuritis in neuromyelitis optica spectrum disorders and multiple sclerosis	25
Hypersomnia in anti‐glutamic acid decarboxylase 65 (GAD65) associated neurological syndromes: A pilot study	25
Care in Europe after presenting to the emergency department with a seizure; position paper and insights from the European Audit of Seizure Management in Hospitals	25
Apolipoprotein E epsilon4 allele is associated with better performance language and visual memory in spinocerebellar ataxia type 3	25
Education for fatigue management in people with multiple sclerosis: Systematic review and meta‐analysis	25
Generative artificial intelligence in neurology: Opportunities and risks	25
Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response	25
Dehydration associates with lower urinary tract symptoms in progressive multiple sclerosis	25
Use of antihypertensive medication and formation of de novo intracranial aneurysms	24
Symposia	24
A diagnostic framework to identify vestibular involvement in multi‐sensory neurological disease	24
Letter to the Editor in response to “Hepatitis E virus and Bell’s palsy”	24
Social cognition deficits in amyotrophic lateral sclerosis: A pilot cross‐sectional population‐based study	24
Elevated Serum MCP‐2 and TARC Associated With Increased Risk of Death in Guamanian ALS Patients	24
Development of Machine‐Learning‐Based Models for Detection of Cognitive Impairment in Patients Receiving Maintenance Hemodialysis	24
Data‐Driven Clustering Approach to Identify Different Phenotypes of Primary Central Nervous System Vasculitis	24
ePresentations	24
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome	24
Meningoencephalitis due to Mycobacterium lentiflavum in an immunocompromised patient: Case report	23
Exercise induced muscle blood flow is decreased in Charcot–Marie–Tooth disease type 1 polyneuropathy: a power Doppler analysis	23
Quantitative Brain MRI Analysis in Neurodegenerative Langerhans Cell Histiocytosis	23
Epilepsy Management in Transgender Population: More Research for Better Treatment	23
Key priorities in rare neurological diseases: A statement from the Coordinating Panel on Rare Neurological Diseases of the European Academy of Neurology	23
Comment on “Association between depression and motoric cognitive risk syndrome among community‐dwelling older adults in China: A 4‐year prospective cohort study”	23
Issue Information	23
Clinical presentation and neural correlates of stroke‐associated spatial delusions	23
Association of aberrant brain network dynamics with gut microbial composition uncovers disrupted brain–gut–microbiome interactions in irritable bowel syndrome: Preliminary findings	23
Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status	23
Longitudinal analysis of anthropometric measures over 5 years in patients with Friedreich ataxia in the EFACTS natural history study	23
Cardioembolic Breakthrough Stroke: When Anticoagulation Fails, Is Left Atrial Appendage Closure the Next Step?	22
Plenary Sessions	22
Socioeconomic status as a risk factor for motoric cognitive risk syndrome in a community‐dwelling population: A longitudinal observational study	22
Clinical and Genetic Characterization of the Largest Cohort of Patients With D3 Limb‐Girdle Muscular Dystrophy in an Isolated Uruguayan Population	22
Smartphone and custom‐made software to assess the effect of botulinum toxin in essential blepharospasm: Initial results	22
	22
Comparison between PFN1 and SOD1 mutations in amyotrophic lateral sclerosis	22
Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke	22
Glutamine Metabolism and Metabolic Profiling Using 7 T CRT‐FID MRSI in Focal Epilepsy	22
Non‐alcoholic fatty liver disease and stroke: A Mendelian randomization study	22
Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis	22
Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis	22
The spectrum of central nervous system involvement in Whipple's disease	22
Distinctive Progression Patterns of Brain Structural Damage Aid Classification of Frontotemporal Dementia Variants	22
Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid‐refractory multiple sclerosis relapses	21
Retrograde Amnesia in LGI1 and CASPR2 Limbic Encephalitis: Two Case Reports and a Systematic Literature Review	21
Spontaneous intracranial hypotension — Neurological symptoms, diagnosis, and outcome	21
Comparative Analysis of SiMoA and Ella Immunoassay Platforms for Measuring Serum Neurofilament Light Chain Levels in ATTRv With Polyneuropathy and Presymptomatic Carriers	21
Latency of poststroke epilepsy can predict drug resistance	21
Spinal muscular atrophy: Should we prescribe approved drugs to cohorts of patients in which they are unproven?	21
Quantification of muscle involvement in familial amyloid polyneuropathy using MRI	21
Hormone therapy and disease activity in Danish women with multiple sclerosis: A population‐based cohort study	21
Mutations in alpha‐B‐crystallin cause autosomal dominant axonal Charcot–Marie–Tooth disease with congenital cataracts	21
Parkinson´s disease cardiovascular symptoms: A new complex functional and structural insight	21
Neurofilament light chain and profilin‐1 dynamics in 30 spinal muscular atrophy type 3 patients treated with nusinersen	20
Optimal cut‐off value of the modified Toronto Clinical Neuropathy Score in the diagnosis of polyneuropathy	20
Prospective follow‐up study of youth and adults with onset of functional tic‐like behaviours during the COVID‐19 pandemic	20
Quantitative proteomic analysis of cerebrospinal fluid from patients with idiopathic facial nerve palsy	20
Prolonged venous transit is associated with lower odds of excellent recovery after reperfusion in anterior large‐vessel occlusion stroke	20
Cerebrotendinous xanthomatosis: A complex interplay between a clinically and genetically heterogeneous condition	20
Post‐ COVID ‐Syndrome Patients Might Overestimate Own Cognitive Impairment	20
A fast and non‐invasive artificial intelligence olfactory‐like system that aids diagnosis of Parkinson's disease	20

Serum neurofilament light chain does not detect self‐reported treatment‐related fluctuations in chronic inflammatory demyelinating polyneuropathy	20
The many faces of globular glial tauopathy: A clinical and imaging study	20
Association between COVID‐19 vaccination and myasthenia gravis: A population‐based, nested case–control study	20
New cellular imaging‐based method to distinguish the SPG4 subtype of hereditary spastic paraplegia	20
Combined Brain‐Cardiac CT in Ischemic Stroke: Unveiling Atrial Markers Linked to Large Vessel Occlusion in AF Patients	20
Tracking myasthenia gravis severity over time: Insights from the French health insurance claims database	20
Association between choroid plexus volume and cognition in Parkinson disease	20
Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy	20
Diagnostic accuracy of nerve ultrasonography for the detection of peripheral neuropathy in type 2 diabetes	19
Corrigendum	19
Long‐term follow‐up of 64 children with classical infantile‐onset Pompe disease since 2004: A French real‐life observational study	19
Confirmed disability progression as a marker of permanent disability in multiple sclerosis	19
Structural Alterations Associated With Cardiovascular Autonomic Failure in Multiple System Atrophy	19
Corrigendum	19
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)	19
HAPLN3 p.T34A contributes to incomplete penetrance of moyamoya disease in Chinese carrying RNF213 p.R4810K	19
Histopathological characterization of cerebral small vessel disease in epilepsy patients with temporal lobe epilepsy submitted to surgery: A case–control study	19
Brain Iron Alteration in Pediatric Tourette Syndrome: A Quantitative Susceptibility Mapping Study	19
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial	19
The effect of head‐down tilt in experimental acute ischemic stroke	18
The impact of hybrid immunity on immune responses after SARS‐CoV‐2 vaccination in persons with multiple sclerosis treated with disease‐modifying therapies	18
History of Traumatic Brain Injury Does Not Influence Rate of Progression of Clinical or Pathological Outcomes in Two Early Parkinson's Disease Cohorts	18
Glymphatic Function in Prodromal Parkinson's Disease: Associations With Symptoms, Gray Matter Volume, and Phenoconversion Risk	18
Three to four mRNA COVID‐19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization	18
Plenary Symposium	18
Aetiology of Acute Respiratory Insufficiency in Patients With Ischaemic Stroke Studied by Chest CT Scan	18
Central vein sign and paramagnetic rim sign: From radiologically isolated syndrome to multiple sclerosis	18
Polygenic risk of Alzheimer's disease in the Faroe Islands	18
Relationship between migraine and epilepsy in a large population‐based cohort: The HUNT Study	18
Symposia	18
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis	18
Decrement of choroid vascularization during spontaneous migraine attacks: An optical coherence tomography angiography study	18
Global Health Inequalities in the Burden of Ischemic Stroke From 1990 to 2021	18
Global Temporal Trends and Projections of Stroke Among Women of Childbearing Age: An Age–Period–Cohort Analysis Based on the Global Burden of Disease Study 2021	18
Giancarlo COMI (1947–2024)	18
Optimizing Prehospital Acute Transfer of Patients With Presumed Stroke Given Economic Constraints	18
Autoimmune encephalitis: Should we consider third‐line immunotherapies earlier?	18
Issue Information	18
Midline sacral meningeal cysts: Neurophysiology abnormalities and their correlation with pelvic sensory and visceral symptoms	18
Sex differences in early‐onset Alzheimer's disease	18
Cost‐effectiveness of surgical treatment compared to medical treatment in patients with drug‐refractory epilepsy: A systematic review	18
Quantitative magnetic resonance neurographic characterization of peripheral nerve involvement in manifest and pre‐ataxic spinocerebellar ataxia type 3	18
Special Sessions	18
Diagnostic Yield of Anti‐Neuronal Antibody Testing in Patients Suspected of an Infectious Encephalitis	17
Lower cerebral arterial blood flow is associated with greater serum neurofilament light chain levels in multiple sclerosis patients	17
Safety and Effectiveness of PCSK9 Inhibitors and Inclisiran in Patients With Neuromuscular Disorders and Statin Intolerance	17
Cannabis and Cognitive Function in Multiple Sclerosis: Findings From a Large Consecutive Clinical Sample	17
Expert opinions on pharmacological symptomatic treatment of behavioral symptoms in frontotemporal dementia: A survey of the Neuropsychiatric International Consortium on Frontotemporal Dementia (NIC‐FT	17
Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia	17
Peripherin: A Novel Early Diagnostic and Prognostic Plasmatic Biomarker in Amyotrophic Lateral Sclerosis	17
Cerebral Amyloid Angiopathy‐Related Inflammation in Iatrogenic Cerebral Amyloid Angiopathy	17
Association of short‐term exposure to ambient air pollution with mortality from ischemic and hemorrhagic stroke	17
Analysis of individual alpha frequency in a large cohort from a tertiary memory center	17
Functional outcome after initial and multiple intracerebral hemorrhages in children with cerebral cavernous malformations	17
Iatrogenic systemic botulism after intragastric botulinum neurotoxin injection: Case report	17
Clinical autonomic nervous system laboratories in Europe	16
Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID‐19	16
	16
Clinical outcomes of delayed mechanical thrombectomy: Descriptive analysis and development of a screening tool	16
A comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody‐associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis	16
Early infantile epileptic encephalopathy related to NECAP1: Clinical delineation of the disease and review	16
Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial	16
Unraveling brain fog in post‐COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms	16
	16
Long‐Term Effectiveness of Early Versus Late Microvascular Decompression for Trigeminal Neuralgia Secondary to Arterial Compression	16
Focused Workshops	16
European Academy of Neurology guidance for developing and reporting clinical practice guidelines on rare neurological diseases	16
Parkinson disease following COVID‐19: Report of six cases	16
	16
Nonstenotic intracranial atherosclerosis as an emerging mechanism in cryptogenic cerebral embolism	16
Clinical Findings in Temporal Lobe Epilepsy Associated With Isolated Amygdala Enlargement	16
Split Hand Syndrome in Charcot–Marie–Tooth Disease Type X1 (CMTX1): A Clinical, Neurophysiological, and Radiological Study	16
Compassionate mind training for people with Parkinson's disease: A pilot study and predictors of response	16
Breast Cancer Screening in Women With Multiple Sclerosis: A Mixed‐Methods Study	15
Thank You to Our Peer Reviewers in 2024	15
Impact of relative cerebral blood volume reduction on early neurological improvement in extensive ischemic stroke	15
Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer’s disease	15
Association of diabetes mellitus with dementia‐ and non‐dementia‐related mortality amongst women: a secondary competing risks analysis of the California Teachers Study	15
Correction to “Tirofiban Benefits the Outcome of Stroke Patients With Large Artery Atherosclerosis Achieving Full Reperfusion and High NIHSS Scores”	15
Dementia among international migrants: An urgent call for better care	15
	15
Suicide Risk and Associated Factors in Parkinson Disease: A Nationwide Cohort Study	15
Epilepsy Stands Nearby: A Pilot CT Perfusion Study on Post‐Stroke Non‐Convulsive Status Epilepticus	15
Nerve Conduction Abnormalities Beyond Conduction Block in Multifocal Motor Neuropathy. Impact on Diagnostic Criteria Accuracy	15
Small Fiber Morphology and Function in Inclusion Body Myositis—A Multimodal Assessment Including Confocal Corneal Microscopy	15
A founder variant in the RYR1 gene is associated with hyperCKemia, myalgia and muscle cramps	14
Icatibant averting mechanical ventilation in acute ischemic stroke patient with alteplase‐induced orolingual angioedema	14
Response to the Letter to the Editor in response to “Hepatitis E virus and Bell’s palsy”	14
Upper motor neuron dysfunction is associated with the presence of behavioural impairment in patients with amyotrophic lateral sclerosis	14
Neurological autoimmunity in patients with non‐pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles	14
Plasma neuropeptide Y levels and adverse clinical outcomes after acute ischaemic stroke	14
The 20th anniversary of the first clinical use of Stalevo®	14
Ultrasonic detection of vagus, accessory, and phrenic nerve atrophy in amyotrophic lateral sclerosis: Relation to impairment and mortality	14
Reorganization of sensory networks after subcortical vestibular infarcts: A longitudinal symptom‐related voxel‐based morphometry study	14
Association Between Migraine and Periodontitis: A Systematic Review and Meta‐Analysis	14